The companies signed a distribution agreement this week covering Croatia, Bosnia-Herzegovina, Slovenia, Serbia, Montenegro, and Macedonia.
The deal covers RosettaGX Reveal, a microRNA-based assay used to classify indeterminate thyroid nodules.
Israel-based Best Medical Opinion and South Korea-based Dow Biomedica/Biodiscovery will distribute Oncimmune's EarlyCDTLung cancer test in those countries.
GenDx will distribute Infopia's GeneFinder line of HLA real-time PCR assays in Europe. GenDx can also sell the kits through its own local distributor network.
GenDx is planning to get CE marking for an Ion Torrent-based HLA typing workflow, to add to the firm's set of NGS solutions for transplant diagnostics.
The deal covers Mobidiag's full line of Amplidiag tests for gastrointestinal infections, as well as the high-throughput Amplidiag Easy system.
Lab21 will serve as a non-exclusive distributor of the SelectMDx prostate cancer test in the UK.
Dr Risch Medical Laboratory will distribute the firm's PCR-based colorectal cancer blood test in the Swiss German market and Lichtenstein.
The NephroCheck test combined with a recommended-care procedure reduced the occurrence of moderate-to-severe AKI following cardiac surgery by 33.9 percent, Astute said.
Progenetics will distribute GeneStrat and Veristrat liquid biopsy tests in Israel, making Biodesix's tests available in the Middle East for the first time.